Alpa Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹31.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.09 per cent from ₹29.05 crore. This corresponds to a year-on-year *(YoY) decline of 21.34 per cent.
Operating Profit
Operating Profit stands at ₹3.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 138.41 per cent from ₹1.51 crore. This corresponds to a year-on-year *(YoY) growth of 1,700.00 per cent.
PBDT
PBDT stands at ₹3.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.08 per cent from ₹2.40 crore. This corresponds to a year-on-year *(YoY) growth of 23.68 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 75.43 per cent from ₹1.75 crore. This corresponds to a year-on-year *(YoY) growth of 47.60 per cent.
Net Profit
Net Profit stands at ₹1.38 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.21 per cent from ₹1.59 crore. This represents a 165.09 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Alpa Laboratories Ltd Earnings
- YOY
- QOQ
Alpa Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alpa Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Alpa Laboratories Ltd Financial Reports
Alpa Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alpa Laboratorie | 0.42% | -0.90% | -0.89% | 9.52% | -16.02% | -30.99% |
| Auro Labs. | -1.05% | -4.78% | -2.68% | -11.74% | 6.69% | -10.51% |
| Novelix Pharma. | 11.02% | 24.36% | 19.39% | 23.35% | 17.91% | 123.32% |
| Parnax Lab | -1.39% | 5.13% | -21.16% | -0.47% | 11.55% | 16.74% |
| Krebs Biochem | -0.82% | -0.37% | 7.09% | 26.04% | -3.40% | -38.75% |
| Bal Pharma | 0.83% | -1.17% | 0.95% | 25.07% | 19.15% | -13.53% |
| Lactose (India) | -3.81% | 0.14% | -0.32% | 11.09% | -5.45% | 11.71% |
Company Info
Company Information
Chairman & Exec. Director : Mahendra Singh Chawla
E D & Wholetime Director : Vitthal Kothana
ED / MD / Promoter : Paresh Chawla
WTD & Executive Director : Pravin C Shah
WTD & Executive Director : Shitul Shah
Independent Non Exe. Director : Pratik Shah
Independent Non Exe. Director : Jyoti Jain
Independent Non Exe. Director : BAHETI SANKET
Independent Non Exe. Director : Sunil Valecha
Independent Non Exe. Director : Pratibha Lunawat